Royal Road expands Margaritas high-grade silver-gold-antimony vein footprint to 400x450 meters in Colombia GAM project
Bitget2026/10/07 12:03Royal Road Minerals reported mapping and sampling that expanded the high-grade silver-gold-antimony vein footprint at Margaritas, Colombia, to about 400 by 450 meters. Vein system remains open to the north and at depth; mineralization interpreted to extend to at least 330 meters below surface. Prior drilling hit high-grade intervals, including 4 meters at 631 g/t silver from 177 meters in MAR-DD-002. Surface rock-chip sampling returned up to 475 g/t silver; gold up to 5.53 g/t; antimony up to 987 ppm. Planned drilling in the current GAM campaign targets newly mapped veins, also tests porphyry-style alteration northeast of prior holes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royal Road Minerals Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610070800NEWSFILECNPR____20261007_317850_1) on October 07, 2026, and is solely responsible for the information contained therein.
- Royal Road Minerals reported mapping and sampling that expanded the high-grade silver-gold-antimony vein footprint at Margaritas, Colombia, to about 400 by 450 meters.
- Vein system remains open to the north and at depth; mineralization interpreted to extend to at least 330 meters below surface.
- Prior drilling hit high-grade intervals, including 4 meters at 631 g/t silver from 177 meters in MAR-DD-002.
- Surface rock-chip sampling returned up to 475 g/t silver; gold up to 5.53 g/t; antimony up to 987 ppm.
- Planned drilling in the current GAM campaign targets newly mapped veins, also tests porphyry-style alteration northeast of prior holes.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Halozyme shares rise after winning a case against Merck's injectable Keytruda in a Dutch court
October 7 – Halozyme (HALO.O) shares rose 1.4% pre-market to $111.24. Halozyme announced it had obtained an injunction from a Dutch court (link), prohibiting Merck MRK.N from manufacturing, selling, and importing subcutaneous Keytruda in eight European markets. The court determined that Merck had infringed Halozyme’s EP622 patent and rejected Merck’s claims that the patent was invalid. Halozyme stated that patients will still have access to the intravenous version of Keytruda, which is not affected by the injunction. As of the close of the previous trading day, HALO shares have risen 62% this year. (For non-English speakers, Reuters automatically translates its reports into several languages. Due to possible errors or missing context in automated translations, Reuters does not guarantee the accuracy of such translated texts, which are provided for readers’ convenience only. Reuters assumes no liability for any damages or losses caused by use of the automated translation function.)
BUZZ-KeyBanc upgrades Corteva rating to "Overweight"; stock price rises
On October 7, KeyBanc upgraded the rating of agricultural technology company Corteva Inc (CTVA.N) from "Sector Weight" to "Overweight." CTVA rose 1.6% in pre-market trading to $14.1. The brokerage pointed out that new product launches, cost reductions, and improvements in farmers' economic conditions will be strong growth drivers for 2028-2029. The company’s ample cash reserves enable it to flexibly fund growth initiatives, stock buybacks, and potential acquisitions. Out of 23 brokerages, 16 have given the stock a "Buy" or higher rating, and 7 have rated it "Hold." The median target price is $18. As of the previous trading day's close, the stock had gained 38.3% year to date.
Antofagasta’s Centinela strike adds copper supply risk
Elon Musk personally defines Terafab: TSMC can at most "sublease a portion," operation is out of the question.
Musk clarified that Terafab will be independently constructed and operated, with TSMC possibly subleasing part of the site; Intel will be involved in technology development and will supply Tesla and SpaceX AI.
Crypto prices
More
